Immune modulation by epidermal cell products: Possible role of ETAF in inflammatory and neoplastic skin diseases - 07/10/17
Doi : 10.1016/S0190-9622(82)70145-8
Daniel N. Sauder, M.D. ⁎, Stephen I. Katz, M.D., Ph.D.
From the Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, and McMaster University, Hamilton.
aReprint requests to: Dr. Daniel N. Sauder, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. L8N 3Z5.
Résumé |
Recent studies have indicated that the epidermis plays an important role in the modulation of immunologic reactions. The factors involved in these processes include not only Langerhans cells but also keratinocyte products. One of these products, ETAF (Epidermal cell derived Thymocyte Activating Factor), which is similar to the macrophage derived product interleukin 1 (IL-1), is reviewed. Speculations as to its possible role in skin diseases are presented.
Le texte complet de cet article est disponible en PDF.© 1982
Publié par Elsevier Masson SAS.
Vol 7 - N° 5
P. 651-654 - novembre 1982 Retour au numéro
Article précédent
- A new look at conditioned hyperirritability
- Susan S. Roper, Henry Earl Jones
- Metastatic basal cell carcinoma of the skin : Metastasis to the skeletal system producing myelophthisic anemia
- Charles Kleinberg, Remedios B. Penetrante, Halina Milgrom, John W. Pickren
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?